These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 30455684

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Eosinophil-derived neurotoxin enhances airway remodeling in eosinophilic chronic rhinosinusitis and correlates with disease severity.
    Tsuda T, Maeda Y, Nishide M, Koyama S, Hayama Y, Nojima S, Takamatsu H, Okuzaki D, Kinehara Y, Kato Y, Nakatani T, Obata S, Akazawa H, Shikina T, Takeda K, Hayama M, Inohara H, Kumanogoh A.
    Int Immunol; 2019 Feb 06; 31(1):33-40. PubMed ID: 30239772
    [Abstract] [Full Text] [Related]

  • 5. γδT cells contribute to type 2 inflammatory profiles in eosinophilic chronic rhinosinusitis with nasal polyps.
    Li X, Wang Z, Chang L, Chen X, Yang L, Lai X, Li S, Huang J, Huang Z, Wu X, Bellanti JA, Zheng SG, Zhang G.
    Clin Sci (Lond); 2019 Nov 29; 133(22):2301-2315. PubMed ID: 31722010
    [Abstract] [Full Text] [Related]

  • 6. IL-5 and IL-6 are increased in the frontal recess of eosinophilic chronic rhinosinusitis patients.
    Kubota K, Takeno S, Taruya T, Sasaki A, Ishino T, Hirakawa K.
    J Otolaryngol Head Neck Surg; 2017 May 02; 46(1):36. PubMed ID: 28464955
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lower Airway Inflammation in Eosinophilic Chronic Rhinosinusitis as Determined by Exhaled Nitric Oxide.
    Kambara R, Minami T, Akazawa H, Tsuji F, Sasaki T, Inohara H, Horii A.
    Int Arch Allergy Immunol; 2017 May 02; 173(4):225-232. PubMed ID: 28848094
    [Abstract] [Full Text] [Related]

  • 9. Expression of heme oxygenase-1 in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps: modulation by cytokines.
    Yu Z, Wang Y, Zhang J, Li L, Wu X, Ma R, Han M, Xu G, Wen W, Li H.
    Int Forum Allergy Rhinol; 2015 Aug 02; 5(8):734-40. PubMed ID: 25907676
    [Abstract] [Full Text] [Related]

  • 10. Group 2 innate lymphoid cells are increased in nasal polyps in patients with eosinophilic chronic rhinosinusitis.
    Tojima I, Kouzaki H, Shimizu S, Ogawa T, Arikata M, Kita H, Shimizu T.
    Clin Immunol; 2016 Sep 02; 170():1-8. PubMed ID: 27422491
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pathological and therapeutic implications of eosinophil-derived semaphorin 4D in eosinophilic chronic rhinosinusitis.
    Tsuda T, Nishide M, Maeda Y, Hayama Y, Koyama S, Nojima S, Takamatsu H, Okuzaki D, Morita T, Nakatani T, Kato Y, Nakanishi Y, Futami Y, Suga Y, Naito Y, Konaka H, Satoh S, Naito M, Izumi M, Obata S, Nakatani A, Shikina T, Takeda K, Hayama M, Inohara H, Kumanogoh A.
    J Allergy Clin Immunol; 2020 Mar 02; 145(3):843-854.e4. PubMed ID: 32035658
    [Abstract] [Full Text] [Related]

  • 13. Increased exhaled nitric oxide and its oxidation metabolism in eosinophilic chronic rhinosinusitis.
    Takeno S, Taruya T, Ueda T, Noda N, Hirakawa K.
    Auris Nasus Larynx; 2013 Oct 02; 40(5):458-64. PubMed ID: 23489830
    [Abstract] [Full Text] [Related]

  • 14. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
    Shin HW, Kim DK, Park MH, Eun KM, Lee M, So D, Kong IG, Mo JH, Yang MS, Jin HR, Park JW, Kim DW.
    J Allergy Clin Immunol; 2015 Jun 02; 135(6):1476-85.e7. PubMed ID: 25725991
    [Abstract] [Full Text] [Related]

  • 15. CD8(+) T cells with distinct cytokine-producing features and low cytotoxic activity in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps.
    Ma J, Shi LL, Deng YK, Wang H, Cao PP, Long XB, Zhang XH, Liu Y, Zeng M, Liu Z.
    Clin Exp Allergy; 2016 Sep 02; 46(9):1162-75. PubMed ID: 27176491
    [Abstract] [Full Text] [Related]

  • 16. Expression of IL-33 and its receptor ST2 in chronic rhinosinusitis with nasal polyps.
    Baba S, Kondo K, Kanaya K, Suzukawa K, Ushio M, Urata S, Asakage T, Kakigi A, Suzukawa M, Ohta K, Yamasoba T.
    Laryngoscope; 2014 Apr 02; 124(4):E115-22. PubMed ID: 24122812
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activation of STAT6 by intranasal allergens correlated with the development of eosinophilic chronic rhinosinusitis in a mouse model.
    Wei H, Xu L, Sun P, Xing H, Zhu Z, Liu J.
    Int J Immunopathol Pharmacol; 2022 Apr 02; 36():3946320221109529. PubMed ID: 35726645
    [Abstract] [Full Text] [Related]

  • 19. IL-17A facilitates type 2 inflammation in a modified eosinophilic chronic rhinosinusitis mouse model.
    Wu H, Wang Z, Li X, Chen X, Li Y, Huang W, Chang L, Zhang G.
    Int Forum Allergy Rhinol; 2023 Sep 02; 13(9):1726-1737. PubMed ID: 36716409
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.